Jeff Nelson, VP Program Management, Mateon Therapeutics, explores the rise of specialist payment...
Expert Insights: Fifteen Percent of 503B Compounding Outsourcing Facilities Have Violated FDA Regulations
Adam Bradbury, MSc, Analyst, PharmSource, investigates why trial facilities are violating FDA regulations
Industry Viewpoints: Refining Your Outsourcing Strategy
Nadia Salem, Senior Director Medical Affairs, Leadiant Biosciences, explains to CTA’s Elizabeth Williams the keys to enhancing your outsourcing strategy
Industry Viewpoints: Effectively Outsourcing Early Phase Clinical Trials
CTA’s Elizabeth Williams catches up with Jeffrey Hausfeld, CMO, BioFactura, on the complexities of carrying out early phase studies
Biopharmaceuticals and the DACH Region: The Availability of Patients in Austria, Germany and Switzerland
CTA’s Adeola Coker explores why patient recruitment remains a challenge in the DACH region
Industry Viewpoints: Strategic Overview and Risk Management in Clinical Operations
Dr Joachim Luithle, VP, Head Clinical Development Operations, Bayer, speaks to CTA’s Adeola Coker about risk management in clinical operations
Read our magazine
Global Defence Technology is the essential reading material for decision-makers in the defence industry, bringing you the latest news and analysis in an exciting, interactive format.